RENTHYROID
Live / Registered — Registered (as of 17 Feb 2026)
What this means for you
Registered since 17 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98598839
- Registration number
- 8146835
- Mark type
- Stylized text
- Filed
- 13 Jun 2024
- Published for opposition
- 08 Oct 2024
- Registered
- 17 Feb 2026
- Attorney of record
- Vladimir I. Arezina
Goods and services
- Class 005 — Pharmaceuticals: Thyroid hormone preparations
Owner
- Genus Lifesciences, Inc., Allentown, PA, US
- Genus Lifesciences, Inc., Allentown, PA, US
- Genus Lifesciences, Inc., Allentown, PA, US
Prosecution history
- 17 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 27 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Jan 2026 — ASSIGNED TO EXAMINER
- 21 Aug 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Jul 2025 — USE AMENDMENT FILED
- 30 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 23 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jul 2025 — SOU EXTENSION 1 GRANTED
- 18 May 2025 — SOU EXTENSION 1 FILED
- 21 Jul 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Jun 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 23 Jun 2025 — NOTICE OF REVIVAL - E-MAILED
- 23 Jun 2025 — PETITION TO REVIVE-GRANTED